IndiaTickerConcord Drugs Ltd - 538965 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Company dossier
Concord Drugs
BSE:CONCORD · ISIN INE858L01010
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Concord Drugs
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Concord Drugs Ltd - 538965 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Concord Drugs Ltd - 538965 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Financial Results For Year Ending 31St March,2026BSE · financial results · pdf
Source filing Concord Drugs Ltd - 538965 - Financial Results For Period Ended 31St March,2026BSE · financial results · pdf
Source filing Concord Drugs Ltd - 538965 - Board Meeting Outcome for Approval Of Financial ResultsBSE · financial results · pdf
Source filing Concord Drugs Ltd - 538965 - Financial Results For Period Ended 31St March,2026BSE · financial results · pdf
Source filing Concord Drugs Ltd - 538965 - Board Meeting Intimation for Audited Results For Year Ending 31.03.2026BSE · financial results · pdf
Source filing Concord Drugs Ltd - 538965 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2BSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - General UpdateBSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Financial Results For Quarter Ended 31St Dec,2025BSE · financial results · pdf
Source filing Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-RetirementBSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Board Meeting Outcome for Out Come Of Board MeetingsBSE · financial results · pdf
Source filing Concord Drugs Ltd - 538965 - Reconstitution Of CommitteesBSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Board Meeting Intimation for Quarterly ResultsBSE · financial results · pdf
Source filing Concord Drugs Ltd - 538965 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderBSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015BSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Concord Drugs Ltd - 538965 - Board Meeting Outcome for Outcome Of Board Meeting For Allotment Of Equity Shares And Convertible WarrantsBSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-AllotmentBSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Financial Results For Quarter Ended 30 Sep 2025BSE · financial results · pdf
Source filing Concord Drugs Ltd - 538965 - Board Meeting Outcome for Outcome Of Board MeetingBSE · financial results · pdf
Source filing Concord Drugs Ltd - 538965 - Board Meeting Intimation for Quarterly ResultsBSE · financial results · pdf
Source filing Concord Drugs Ltd - 538965 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Concord Drugs Ltd - 538965 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Source filing